ITRM vs PFE · rev $390.0K vs P/E 20, rev $62.58B
Iterum Therapeutics PLC (ITRM) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ITRM currently screens at market cap $38.6M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ITRM and PFE stock pages for the full models.
Not investment advice.